<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02409017</url>
  </required_header>
  <id_info>
    <org_study_id>690224-2</org_study_id>
    <nct_id>NCT02409017</nct_id>
  </id_info>
  <brief_title>A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial</brief_title>
  <official_title>A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>WellSpan Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>WellSpan Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess which of two commonly utilized insulin drip protocols has better outcomes when used
      during the labor process.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of time and participation in the study
  </why_stopped>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean maternal glucose</measure>
    <time_frame>Labor</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Protocol A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Our current standard during labor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Another commonly accepted alternative for insulin drip management during labor</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insulin drip</intervention_name>
    <arm_group_label>Protocol A</arm_group_label>
    <arm_group_label>Protocol B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a. Pregnant patients with either pre-existing diabetes or gestational diabetes type A2
             who require insulin for euglycemia during labor and delivery

        Exclusion Criteria:

          -  a. Those patients who decline participation

          -  b. Patients less than age 18 at the time of enrollment will be excluded to protect
             this vulnerable patient population c. Those patients who cannot be consented d.
             Patients scheduled for cesarean delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>WellSpan York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 2, 2015</study_first_submitted>
  <study_first_submitted_qc>April 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2015</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>WellSpan Health</investigator_affiliation>
    <investigator_full_name>Tara L. Moore</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>insulin drip</keyword>
  <keyword>labor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

